IRD Opus Genetics, Inc.
Nasdaq · SEC CIK 1228627 · EDGAR
- Bought, last 12 months
- $323.9K 2 purchases by 1 insiders
- Sold, last 12 months
- $16.59M 17 sales by 7 insiders
- Filings on record
- 155 since 2021-07-02, latest 2026-09-11 16:09
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| Gallagher Cam | Dir | $323.9K | — |
| Magrath George | CEO, Dir | — | $204.9K |
| Gagnon Robert E. | CFO | — | $190.8K |
| YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| SCHACHLE JOSEPH K | COO | — | $57.7K |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| Bennett Jean | Dir | — | — |
| Ainsworth Sean | Dir | — | — |
Transactions 146
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-11 16:09 | 2026-09-09 | IRD | Magrath George | CEO, Dir | M - OptEx | $1.15 | +392.2K | 2.12M | +23% | +$451.0K |
| D | 2026-09-11 16:09 | 2026-09-09 | IRD | Magrath George | CEO, Dir | F - Tax | $5.97 | -75.5K | 2.05M | -4% | -$451.0K |
| D | 2026-09-08 16:05 | 2026-09-08 | IRD | Gallagher Cam | Dir | M - OptEx | $1.15 | +784.3K | 2.80M | +39% | +$902.0K |
| 2026-09-08 16:05 | 2026-09-03 | IRD | Gagnon Robert E. | CFO | S - Sale | $4.54 | -28.0K | 556.4K | -5% | -$127.2K | |
| 2026-07-27 16:08 | 2026-07-23 | IRD | YERXA BENJAMIN R | Pres, Dir | S - Sale | $2.97 | -7,429 | 704.1K | -1% | -$22.1K | |
| 2026-07-27 16:07 | 2026-07-23 | IRD | SCHACHLE JOSEPH K | COO | S - Sale | $2.94 | -4,644 | 291.4K | -2% | -$13.7K | |
| 2026-07-27 16:07 | 2026-07-23 | IRD | Magrath George | CEO, Dir | S - Sale | $2.95 | -9,475 | 1.73M | -0.5% | -$27.9K | |
| 2026-07-27 16:06 | 2026-07-23 | IRD | Gagnon Robert E. | CFO | S - Sale | $2.95 | -7,783 | 584.4K | -1% | -$22.9K | |
| 2026-05-20 19:29 | 2026-05-18 | IRD | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | S - Sale | $4.35 | -1.70M | 3.79M | -31% | -$7.39M | |
| 2026-04-27 16:28 | 2026-04-23 | IRD | YERXA BENJAMIN R | Pres, Dir | S - Sale | $5.24 | -7,470 | 711.5K | -1% | -$39.1K | |
| 2026-04-27 16:28 | 2026-04-23 | IRD | SCHACHLE JOSEPH K | COO | S - Sale | $5.22 | -4,697 | 296.1K | -2% | -$24.5K | |
| 2026-04-27 16:27 | 2026-04-23 | IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | S - Sale | $5.20 | -1,641 | 188.7K | -0.9% | -$8,540 | |
| 2026-04-27 16:27 | 2026-04-23 | IRD | Magrath George | CEO, Dir | S - Sale | $5.22 | -9,511 | 1.74M | -0.5% | -$49.6K | |
| 2026-04-27 16:26 | 2026-04-23 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | S - Sale | $5.19 | -7,542 | 509.2K | -1% | -$39.2K | |
| 2026-04-27 16:26 | 2026-04-23 | IRD | Gagnon Robert E. | CFO | S - Sale | $5.18 | -7,842 | 592.2K | -1% | -$40.7K | |
| 2026-04-22 16:32 | 2026-04-20 | IRD | Rodgers Richard J | Dir | A - Grant | $0.00 | +24.4K | 343.0K | +8% | $0 | |
| 2026-04-22 16:31 | 2026-04-20 | IRD | MANUSO JAMES S J | Dir | A - Grant | $0.00 | +24.4K | 317.3K | +8% | $0 | |
| 2026-04-22 16:31 | 2026-04-20 | IRD | Graves Adrienne L | Dir | A - Grant | $0.00 | +24.4K | 127.5K | +24% | $0 | |
| 2026-04-22 16:30 | 2026-04-20 | IRD | Gallagher Cam | Dir | A - Grant | $0.00 | +24.4K | 2.02M | +1% | $0 | |
| 2026-04-22 16:30 | 2026-04-20 | IRD | Benton Susan | Dir | A - Grant | $0.00 | +24.4K | 243.9K | +11% | $0 | |
| 2026-04-22 16:28 | 2026-04-20 | IRD | Bennett Jean | Dir | A - Grant | $0.00 | +24.4K | 259.0K | +10% | $0 | |
| 2026-04-22 16:26 | 2026-04-20 | IRD | Ainsworth Sean | Dir | A - Grant | $0.00 | +24.4K | 321.7K | +8% | $0 | |
| 2026-03-18 | 2026-03-16 | IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | S - Sale | $5.25 | -2,816 | 190.3K | -1% | -$14.8K | |
| 2026-03-18 | 2026-03-16 | IRD | SCHACHLE JOSEPH K | COO | S - Sale | $5.25 | -3,719 | 300.8K | -1% | -$19.5K | |
| 2026-03-18 | 2026-03-16 | IRD | Magrath George | CEO, Dir | S - Sale | $5.21 | -24.4K | 1.75M | -1% | -$127.3K | |
| 2026-03-18 | 2026-03-16 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | S - Sale | $5.12 | -3,719 | 516.8K | -0.7% | -$19.0K | |
| 2026-02-17 | 2026-02-12 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | F - Tax | $3.39 | -5,313 | 520.5K | -1% | -$18.0K | |
| 2026-01-26 | 2026-01-22 | IRD | YERXA BENJAMIN R | Pres, Dir | A - Grant | $0.00 | +400.0K | 719.0K | +125% | $0 | |
| 2026-01-26 | 2026-01-22 | IRD | Magrath George | CEO, Dir | A - Grant | $0.00 | +483.6K | 1.78M | +37% | $0 | |
| 2026-01-26 | 2026-01-22 | IRD | SCHACHLE JOSEPH K | COO | A - Grant | $0.00 | +250.0K | 304.5K | +459% | $0 | |
| 2026-01-26 | 2026-01-22 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | A - Grant | $0.00 | +400.0K | 525.8K | +318% | $0 | |
| 2026-01-26 | 2026-01-22 | IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | A - Grant | $0.00 | +86.5K | 193.1K | +81% | $0 | |
| 2026-01-26 | 2026-01-22 | IRD | Gagnon Robert E. | CFO | A - Grant | $0.00 | +400.0K | 600.0K | +200% | $0 | |
| 2026-01-21 | 2026-01-18 | IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | F - Tax | $2.10 | -3,390 | 106.6K | -3% | -$7,119 | |
| 2026-01-13 | 2026-01-10 | IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | F - Tax | $1.93 | -3,950 | 110.0K | -3% | -$7,624 | |
| 2026-01-08 | 2026-01-06 | IRD | Gallagher Cam | Dir | A - Grant | $0.00 | +67.0K | 1.99M | +3% | $0 | |
| 2026-01-05 | 2026-01-01 | IRD | Graves Adrienne L | Dir | A - Grant | — | +23.6K | 103.1K | +30% | — | |
| 2026-01-05 | 2026-01-01 | IRD | MANUSO JAMES S J | Dir | A - Grant | — | +31.2K | 293.0K | +12% | — | |
| 2026-01-05 | 2026-01-01 | IRD | Bennett Jean | Dir | A - Grant | — | +21.1K | 234.7K | +10% | — | |
| 2026-01-05 | 2026-01-01 | IRD | Ainsworth Sean | Dir | A - Grant | — | +42.5K | 297.3K | +17% | — | |
| 2025-12-31 | 2025-12-29 | IRD | Gallagher Cam | Dir | P - Purchase | $1.98 | +81.0K | 1.89M | +4% | +$160.4K | |
| 2025-12-31 | 2025-12-31 | IRD | Gallagher Cam | Dir | A - Grant | $0.00 | +33.0K | 1.92M | +2% | $0 | |
| I | 2025-12-31 | 2025-12-29 | IRD | Gallagher Cam | Dir | P - Purchase | $1.97 | +83.0K | 83.0K | New | +$163.5K |
| 2025-12-11 | 2025-12-09 | IRD | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | S - Sale | $2.15 | -4.00M | 5.49M | -42% | -$8.60M | |
| A | 2025-11-05 | 2025-11-01 | IRD | Magrath George | CEO, Dir | F - Tax | $2.30 | -30.4K | 1.29M | -2% | -$69.8K |
| 2025-11-04 | 2025-11-01 | IRD | Magrath George | CEO, Dir | F - Tax | $2.30 | -30.4K | 1.29M | -2% | -$69.8K | |
| 2025-10-24 | 2025-10-22 | IRD | YERXA BENJAMIN R | Pres, Dir | F - Tax | $1.95 | -23.8K | 319.0K | -7% | -$46.4K | |
| D | 2025-09-11 | 2025-09-10 | IRD | Gagnon Robert E. | CFO | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
| 2025-08-27 | 2025-08-25 | IRD | Gallagher Cam | Dir | A - Grant | $1.15 | +869.6K | 1.81M | +92% | +$1000.0K | |
| 2025-08-27 | 2025-08-25 | IRD | Ainsworth Sean | Dir | A - Grant | $1.15 | +87.0K | 254.8K | +52% | +$100.0K | |
| D | 2025-05-06 | 2025-05-05 | IRD | Foundation Fighting Blindness, Inc. | Dir, 10%, See Remarks | C - Cnv Deriv | — | +6.93M | 9.49M | +270% | — |
| D | 2025-05-02 | 2025-04-30 | IRD | Graves Adrienne L | Dir | A - Grant | $0.00 | +79.5K | 79.5K | New | $0 |
| D | 2025-05-02 | 2025-04-30 | IRD | Gallagher Cam | Dir | A - Grant | $0.00 | +79.5K | 940.9K | +9% | $0 |
| D | 2025-05-02 | 2025-04-30 | IRD | MANUSO JAMES S J | Dir | A - Grant | $0.00 | +79.5K | 261.8K | +44% | $0 |
| D | 2025-05-02 | 2025-04-30 | IRD | Ainsworth Sean | Dir | A - Grant | $0.00 | +79.5K | 167.9K | +90% | $0 |
| D | 2025-05-02 | 2025-04-30 | IRD | Bennett Jean | Dir | A - Grant | $0.00 | +79.5K | 213.5K | +59% | $0 |
| D | 2025-05-02 | 2025-04-30 | IRD | Rodgers Richard J | Dir | A - Grant | $0.00 | +79.5K | 318.7K | +33% | $0 |
| D | 2025-05-02 | 2025-04-30 | IRD | Benton Susan | Dir | A - Grant | $0.00 | +79.5K | 219.5K | +57% | $0 |
| D | 2025-03-26 | 2025-03-24 | IRD | Magrath George | CEO, Dir | A - Grant | — | +392.2K | 1.32M | +42% | — |
| D | 2025-03-26 | 2025-03-24 | IRD | Gallagher Cam | Dir | A - Grant | — | +784.3K | 861.4K | +1,018% | — |
| D | 2025-03-17 | 2025-03-13 | IRD | Jhaveri Nirav S. | CFO | A - Grant | $0.00 | +52.5K | 194.3K | +37% | $0 |
| D | 2025-03-17 | 2025-03-13 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | A - Grant | $0.00 | +52.5K | 125.8K | +72% | $0 |
| D | 2025-03-17 | 2025-03-13 | IRD | SCHACHLE JOSEPH K | COO | A - Grant | $0.00 | +52.5K | 54.5K | +2,625% | $0 |
| D | 2025-03-17 | 2025-03-13 | IRD | Zaremba Rabourn Amy | SVP of Fin | A - Grant | $0.00 | +39.5K | 114.0K | +53% | $0 |
| D | 2025-03-17 | 2025-03-13 | IRD | Magrath George | CEO | A - Grant | $0.00 | +330.7K | 929.8K | +55% | $0 |
| D | 2025-03-17 | 2025-03-13 | IRD | Hoffmann Bernhard | SVP of Corp. Dev | A - Grant | $0.00 | +29.5K | 185.4K | +19% | $0 |
| 2025-02-18 | 2025-02-13 | IRD | Jhaveri Nirav S. | CFO | F - Tax | $1.15 | -8,207 | 141.8K | -5% | -$9,438 | |
| 2025-02-18 | 2025-02-13 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | F - Tax | $1.15 | -5,193 | 73.3K | -7% | -$5,972 | |
| 2025-02-06 | 2025-02-04 | IRD | Zaremba Rabourn Amy | SVP of Fin | F - Tax | $1.14 | -8,190 | 74.5K | -10% | -$9,337 | |
| 2025-02-06 | 2025-02-04 | IRD | Hoffmann Bernhard | SVP of Corp. Dev | F - Tax | $1.14 | -6,751 | 155.9K | -4% | -$7,696 | |
| 2025-01-06 | 2025-01-02 | IRD | Bennett Jean | Dir | A - Grant | — | +34.0K | 134.0K | +34% | — | |
| 2025-01-06 | 2025-01-02 | IRD | MANUSO JAMES S J | Dir | A - Grant | — | +50.2K | 182.3K | +38% | — | |
| 2024-12-30 | 2024-12-26 | IRD | Magrath George | CEO | P - Purchase | $0.98 | +100.0K | 599.1K | +20% | +$98.0K | |
| 2024-12-23 | 2024-12-23 | IRD | Magrath George | CEO | A - Grant | $0.00 | +6,200 | 499.1K | +1% | $0 | |
| 2024-11-25 | 2024-11-21 | IRD | YERXA BENJAMIN R | Pres, Dir | P - Purchase | $0.98 | +10.0K | 342.8K | +3% | +$9,800 | |
| M | 2024-11-19 | 2024-11-15+ | IRD | Magrath George | CEO | P - Purchase | $1.01 | +100.0K | 492.9K | +25% | +$101.1K |
| 2024-11-12 | 2024-11-07 | IRD | YERXA BENJAMIN R | Pres, Dir | A - Grant | $0.00 | +332.8K | 332.8K | New | $0 | |
| 2024-11-05 | 2024-11-01 | IRD | Magrath George | CEO | F - Tax | $1.18 | -37.0K | 392.9K | -9% | -$43.7K | |
| D | 2024-10-24 | 2024-10-22 | IRD | Bennett Jean | Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | Gallagher Cam | Dir | A - Grant | $0.00 | +41.1K | 77.0K | +115% | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | MANUSO JAMES S J | Dir | A - Grant | $0.00 | +41.1K | 132.0K | +45% | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | Benton Susan | Dir | A - Grant | $0.00 | +41.1K | 140.0K | +42% | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | Ainsworth Sean | Dir | A - Grant | $0.00 | +41.1K | 88.4K | +87% | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | Rodgers Richard J | Dir | A - Grant | $0.00 | +41.1K | 239.2K | +21% | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | Pepose Jay | Dir | A - Grant | $0.00 | +41.1K | 180.5K | +30% | $0 |
| 2024-05-24 | 2024-05-22 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | P - Purchase | $1.77 | +3,500 | 78.5K | +5% | +$6,195 | |
| 2024-05-21 | 2024-05-17 | IRD | Magrath George | CEO | P - Purchase | $1.75 | +5,000 | 430.0K | +1% | +$8,750 | |
| D | 2024-04-15 | 2024-04-11 | IRD | Pepose Jay | Dir | A - Grant | $0.00 | +32.0K | 139.3K | +30% | $0 |
| 2024-03-25 | 2024-03-21 | IRD | Jhaveri Nirav S. | CFO | P - Purchase | $2.10 | +10.0K | 150.0K | +7% | +$21.0K | |
| 2024-03-25 | 2024-03-21 | IRD | SCHACHLE JOSEPH K | COO | P - Purchase | $2.05 | +2,000 | 2,000 | New | +$4,100 | |
| 2024-03-20 | 2024-03-18 | IRD | Magrath George | CEO | P - Purchase | $1.96 | +25.0K | 425.0K | +6% | +$49.0K | |
| D | 2024-02-14 | 2024-02-12 | IRD | Jhaveri Nirav S. | CFO | A - Grant | $0.00 | +140.0K | 140.0K | New | $0 |
| D | 2024-02-14 | 2024-02-12 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| D | 2024-01-22 | 2024-01-18 | IRD | Zaremba Rabourn Amy | SVP of Fin | A - Grant | $0.00 | +40.0K | 82.7K | +94% | $0 |
| D | 2024-01-22 | 2024-01-18 | IRD | Hoffmann Bernhard | SVP of Corp. Dev | A - Grant | $0.00 | +20.0K | 162.7K | +14% | $0 |
| 2024-01-12 | 2024-01-10 | IRD | Patel Ronil A. | Chief Business Off | F - Tax | $3.27 | -1,282 | 90.7K | -1% | -$4,192 | |
| 2024-01-12 | 2024-01-10 | IRD | Zaremba Rabourn Amy | SVP of Fin | F - Tax | $3.27 | -3,950 | 42.7K | -8% | -$12.9K | |
| 2024-01-12 | 2024-01-10 | IRD | Hoffmann Bernhard | SVP of Corp. Dev | F - Tax | $3.27 | -4,031 | 142.7K | -3% | -$13.2K | |
| 2024-01-03 | 2024-01-01 | IRD | Benton Susan | Dir | A - Grant | — | +19.4K | 98.9K | +24% | — | |
| 2024-01-03 | 2024-01-01 | IRD | MANUSO JAMES S J | Dir | A - Grant | — | +22.1K | 90.9K | +32% | — |
Purchase Sale Sale after option exercise All abbreviations